Work

Lecanemab’s safety in the CLARITY AD open-label extension: a preliminary update including subcutaneous formulation

Year: 2024

Type: conference-paper

Study design: Clinical Trial

DOI: 10.1136/jnnp-2024-abn.168

Authors: Irizarry Michael, Li David, Dhadda Shobha, Hersch Steven, Reyderman Larisa, McMurray Rob, Warner Michael, Kramer Lynn

Institutions: Barrow Neurological Institute, Eisai (United States), Eisai (United Kingdom)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404183308

FWCI:

Cites:

Cited by:

Related to: 10